Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphate.
Hum Vaccin Immunother
; 11(8): 2030-7, 2015.
Article
em En
| MEDLINE
| ID: mdl-25891359
Palavras-chave
ANOVA, Analysis of Variance; Aluminum phosphate; CFSE, Carboxyfluorescein succinimidyl ester; CTL, Cytotoxic T lymphocyte; ELISA, Enzyme-linked immune-sorbent assay; FACS, Fluorescence-activated cell sorting; GST, Glutathione S-transferase; HPLC, High-performance liquid chromatography; KDR, kinase domain receptor; Ni-NTA, nickel-nitrilotriacetic acid; PBMC, Peripheral blood mononuclear cells; VEGF; VEGF, vascular endothelial growth factor; VEGFR2, vascular endothelial growth factor receptor 2; VSSP, very small sized proteoliposomes; adjuvant; antibodies; cancer therapeutic vaccine
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fosfatos
/
Química Farmacêutica
/
Adjuvantes Imunológicos
/
Compostos de Alumínio
/
Vacinas Anticâncer
/
Fator A de Crescimento do Endotélio Vascular
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article